Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Life Sciences Investor Forum today announced that the presentations from the September 16 th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.

This virtual event showcased live executive presentations and interactive discussions focused on publicly traded companies in the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company's "virtual trade booth".

REGISTER OR LOGIN AT: https://bit.ly/3hFx0MB

September 16 th Presenting Companies:

Presenting Company Ticker(s)
VolitionRx Limited NYSE AMERICAN: VNRX
Avicanna Inc. ( OTCQX: AVCNF | TSX: AVCN)
Alpha Cognition Inc. OTCQB: ACOGF | TSX-V: ACOG
Willow Biosciences Inc. ( OTCQX: CANSF | TSX: WLLW)
Filament Health Corp. ( Pink: FLHLF | NEO: FH)
Novamind Inc. ( OTCQB: NVMDF | CSE: NM)
Salarius Pharmaceuticals, Inc. Nasdaq: SLRX
MedX Health Corp. TSX-V: MDX
Wesana Health Holdings Inc. ( OTCQB: WSNAF | CSE: WESA)
Compass Therapeutics, Inc. OTCQB: CMPX
Else Nutrition Holdings Inc. ( OTCQX: BABYF | TSX-V: BABY)

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com .

About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
johnv@lifesciencesinvestorforum.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
avicanna news

Avicanna

Leading Biopharmaceutical Research and Development of Commercialized Cannabinoid-Based Products for Global Markets

Leading Biopharmaceutical Research and Development of Commercialized Cannabinoid-Based Products for Global Markets Keep Reading...
Cannabis plant in focus, blurred US flag background.

Analysts React: Trump Signs Executive Order to Reschedule Cannabis

The long-debated issue of US cannabis rescheduling is finally back in the spotlight. On Thursday, December 18, President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now... Keep Reading...
Close-up of green cannabis leaves in natural light.

Trump Weighs Executive Order to Loosen Federal Cannabis Restrictions

US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told the Washington Post that Trump is preparing an executive... Keep Reading...
Gavel on a surface with scattered cannabis leaves, symbolizing legal issues around marijuana.

Hemp THC Recriminalization: A Blow to a Blooming Industry

A spending bill to reopen the US government after a 43 day shutdown includes provisions that will recriminalize most hemp-derived THC products. This change, slated to become effective one year after enactment, in late 2026, marks a significant policy reversal from the 2018 Farm Bill, which... Keep Reading...
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...

Interactive Chart

Latest Press Releases

Related News